Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study

Bennett JL., Fujihara K., Saiz A., Traboulsee AL., Greenberg BM., Weinshenker BG., Patti F., Kleiter I., Palace J., De Seze J., Evans R., Blondeau K., Klingelschmitt G., Vodopivec I., Rahim M., Yamamura T.

DOI

10.1212/nxi.0000000000200494

Type

Journal article

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

2025-11-01T00:00:00+00:00

Volume

12

Permalink More information Close